<code id='2685E58203'></code><style id='2685E58203'></style>
    • <acronym id='2685E58203'></acronym>
      <center id='2685E58203'><center id='2685E58203'><tfoot id='2685E58203'></tfoot></center><abbr id='2685E58203'><dir id='2685E58203'><tfoot id='2685E58203'></tfoot><noframes id='2685E58203'>

    • <optgroup id='2685E58203'><strike id='2685E58203'><sup id='2685E58203'></sup></strike><code id='2685E58203'></code></optgroup>
        1. <b id='2685E58203'><label id='2685E58203'><select id='2685E58203'><dt id='2685E58203'><span id='2685E58203'></span></dt></select></label></b><u id='2685E58203'></u>
          <i id='2685E58203'><strike id='2685E58203'><tt id='2685E58203'><pre id='2685E58203'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:65873

          Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

          advertisement

          For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Travel bans should be based on evidence, not politics or fear
          Travel bans should be based on evidence, not politics or fear

          VALERIEMACON/AFPviaGettyImagesTheTrumpWhiteHouseonMondayreleasedapresidentialproclamationterminating

          read more
          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more

          Judge schedules Friday hearing on proposed protective order in Jan. 6 case

          0:58FormerPresidentDonaldTrumppausesforcheersfromthecrowdbeforespeakingasthekeynotespeakeratthe56thA